|
Click on the first letter in the Drug name:
ranibizumab
Generic Name: ranibizumab (ophthalmic) (ra NIB i ZUE mab)
Brand Names: Lucentis
What is ranibizumab?
Ranibizumab is made from a human antibody fragment. It works by keeping new blood
vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In
people with a certain type of eye disease, new blood vessels grow under the retina where they
leak blood and fluid. This is known as the "wet form" of macular degeneration.
Ranibizumab is used to treat the wet form of age-related macular degeneration.
Ranibizumab may also be used for purposes other than those listed in this medication
guide.
What is the most important information I should know about ranibizumab?
Do not receive this medication if you are allergic to ranibizumab, or if you have an
infection in or around your eye. Before you receive this medication, tell your doctor if you have
glaucoma.
Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to
numb your eye before giving you the injection. You will receive this injection in your doctor"s
office or other clinic setting.
Ranibizumab is usually given once a month. After you have received the first 4
injections, your doctor may change your injection schedule to once every 3 months. Follow your
doctor"s instructions.
Call your doctor at once if you have any of these serious side effects: vision changes,
eye pain or redness, discharge or bleeding from your eye, increased eye sensitivity to light,
swelling around the eye, or seeing flashes of light.
Call your doctor for instructions if you miss an appointment to receive your ranibizumab
injection.
What should I discuss with my health care provider before receiving
ranibizumab?
Do not receive this medication if you are allergic to ranibizumab, or if you have an
infection in or around your eye.
Before you receive this medication, tell your doctor if you have glaucoma, or a history of
blood clots or stroke.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell
your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether ranibizumab passes into breast milk or if it could harm a
nursing baby. Do not receive this medication without telling your doctor if you are
breast-feeding a baby.
How is ranibizumab used?
Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to
numb your eye before giving you the injection. You will receive this injection in your doctor"s
office or other clinic setting.
Ranibizumab is usually given once a month. After you have received the first 4
injections, your doctor may change your injection schedule to once every 3 months. Follow your
doctor"s instructions.
For at least 30 minutes after your injection, your eyes will be checked periodically to
make sure the injection has not caused any side effects.
To be sure this medication is helping your condition and not causing harmful effects, your
eyes will also need to be checked on a regular basis. Do not miss any scheduled visits to your
doctor.
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment to receive your ranibizumab
injection.
What happens if I overdose?
Seek emergency medical attention if you think you have received too much of this
medicine. Symptoms of a ranizumab overdose may include eye pain or vision changes.
What should I avoid while receiving ranibizumab?
There are no restrictions on food, beverages, or activity while receiving ranibizumab
unless your doctor has told you otherwise.
Ranibizumab side effects
Get emergency medical help if you have any of these signs of an allergic
reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:
-
vision changes;
-
eye pain, redness, or irritation;
-
discharge or bleeding from the eye;
-
increased eye sensitivity to light;
-
swelling around your eye;
-
seeing "stars" or flashes of light, especially in your
peripheral (side) vision;
-
pain or burning when you urinate.
-
sudden numbness or weakness, especially on one side of the
body; or
-
sudden headache, confusion, problems with vision, speech,
or balance.
Other less serious side effects are more likely to occur, such as:
Side effects other than those listed here may also occur. Talk to your
doctor about any side effect that seems unusual or that is especially bothersome.
What other drugs will affect ranibizumab?
There may be other drugs that can affect ranibizumab. Tell your doctor about all the
prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal
products, and drugs prescribed by other doctors. Do not start using a new medication without
telling your doctor.
Where can I get more information?
-
Your pharmacist has information about ranibizumab written for health professionals that
you may read.
What does my medication look like?
Ranibizumab is available with a prescription under the brand name Lucentis. Other brand
or generic forms may also be available. Ask your pharmacist any questions you have about this
medication, especially if it is new to you.
-
- Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ("Multum") is accurate,
up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum
information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not
warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum"s drug information
does not endorse drugs, diagnose patients or recommend therapy. Multum"s drug information is an informational resource designed to
assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to,
and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given
drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate
for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information
Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug
interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse
or pharmacist.
Copyright 1996-2006 Cerner Multum, Inc. Version: 1.03. Revision Date: 04/25/2007 11:40:45 AM.
Latest news about ranibizumab ophthalmic
Ranibizumab:
{news_rss}
Typical mistypes for ranibizumab ophthalmic
Ranibizumab eanibizumab ophthalmic
ranibizumab, danibizumab ophthalmic
ranibizumab, fanibizumab ophthalmic
ranibizumab, tanibizumab ophthalmic
ranibizumab, 5anibizumab ophthalmic
ranibizumab, 4anibizumab ophthalmic
ranibizumab, rznibizumab ophthalmic
ranibizumab, rsnibizumab ophthalmic
ranibizumab, rwnibizumab ophthalmic
ranibizumab, rqnibizumab ophthalmic
ranibizumab, rabibizumab ophthalmic
ranibizumab, ramibizumab ophthalmic
ranibizumab, rajibizumab ophthalmic
ranibizumab, rahibizumab ophthalmic
ranibizumab, ranubizumab ophthalmic
ranibizumab, ranjbizumab ophthalmic
ranibizumab, rankbizumab ophthalmic
ranibizumab, ranobizumab ophthalmic
ranibizumab, ran9bizumab ophthalmic
ranibizumab, ran8bizumab ophthalmic
ranibizumab, ranivizumab ophthalmic
ranibizumab, raninizumab ophthalmic
ranibizumab, ranihizumab ophthalmic
ranibizumab, ranigizumab ophthalmic
ranibizumab, ranibuzumab ophthalmic
ranibizumab, ranibjzumab ophthalmic
ranibizumab, ranibkzumab ophthalmic
ranibizumab, ranibozumab ophthalmic
ranibizumab, ranib9zumab ophthalmic
ranibizumab, ranib8zumab ophthalmic
ranibizumab, ranibixumab ophthalmic
ranibizumab, ranibisumab ophthalmic
ranibizumab, ranibiaumab ophthalmic
ranibizumab, ranibizymab ophthalmic
ranibizumab, ranibizhmab ophthalmic
ranibizumab, ranibizjmab ophthalmic
ranibizumab, ranibizimab ophthalmic
ranibizumab, ranibiz8mab ophthalmic
ranibizumab, ranibiz7mab ophthalmic
ranibizumab, ranibizunab ophthalmic
ranibizumab, ranibizukab ophthalmic
ranibizumab, ranibizujab ophthalmic
ranibizumab, ranibizumzb ophthalmic
ranibizumab, ranibizumsb ophthalmic
ranibizumab, ranibizumwb ophthalmic
ranibizumab, ranibizumqb ophthalmic
ranibizumab, ranibizumav ophthalmic
ranibizumab, ranibizuman ophthalmic
ranibizumab, ranibizumah ophthalmic
ranibizumab, ranibizumag ophthalmic
ranibizumab, ranibizumab iphthalmic
ranibizumab, ranibizumab kphthalmic
ranibizumab, ranibizumab lphthalmic
ranibizumab, ranibizumab pphthalmic
ranibizumab, ranibizumab 0phthalmic
ranibizumab, ranibizumab 9phthalmic
ranibizumab, ranibizumab oohthalmic
ranibizumab, ranibizumab olhthalmic
ranibizumab, ranibizumab o-hthalmic
ranibizumab, ranibizumab o0hthalmic
ranibizumab, ranibizumab opgthalmic
ranibizumab, ranibizumab opbthalmic
ranibizumab, ranibizumab opnthalmic
ranibizumab, ranibizumab opjthalmic
ranibizumab, ranibizumab oputhalmic
ranibizumab, ranibizumab opythalmic
ranibizumab, ranibizumab ophrhalmic
ranibizumab, ranibizumab ophfhalmic
ranibizumab, ranibizumab ophghalmic
ranibizumab, ranibizumab ophyhalmic
ranibizumab, ranibizumab oph6halmic
ranibizumab, ranibizumab oph5halmic
ranibizumab, ranibizumab ophtgalmic
ranibizumab, ranibizumab ophtbalmic
ranibizumab, ranibizumab ophtnalmic
ranibizumab, ranibizumab ophtjalmic
ranibizumab, ranibizumab ophtualmic
ranibizumab, ranibizumab ophtyalmic
ranibizumab, ranibizumab ophthzlmic
ranibizumab, ranibizumab ophthslmic
ranibizumab, ranibizumab ophthwlmic
ranibizumab, ranibizumab ophthqlmic
ranibizumab, ranibizumab ophthakmic
ranibizumab, ranibizumab ophthapmic
ranibizumab, ranibizumab ophthaomic
ranibizumab, ranibizumab ophthalnic
ranibizumab, ranibizumab ophthalkic
ranibizumab, ranibizumab ophthaljic
ranibizumab, ranibizumab ophthalmuc
ranibizumab, ranibizumab ophthalmjc
ranibizumab, ranibizumab ophthalmkc
ranibizumab, ranibizumab ophthalmoc
ranibizumab, ranibizumab ophthalm9c
ranibizumab, ranibizumab ophthalm8c
ranibizumab, ranibizumab ophthalmix
ranibizumab, ranibizumab ophthalmiv
ranibizumab, ranibizumab ophthalmif
ranibizumab, ranibizumab ophthalmid
ranibizumab, ranibizumab ophthalmic
eanibizumab, ranibizumab ophthalmic
danibizumab, ranibizumab ophthalmic
fanibizumab, ranibizumab ophthalmic
tanibizumab, ranibizumab ophthalmic
5anibizumab, ranibizumab ophthalmic
4anibizumab, ranibizumab ophthalmic
rznibizumab, ranibizumab ophthalmic
rsnibizumab, ranibizumab ophthalmic
rwnibizumab, ranibizumab ophthalmic
rqnibizumab, ranibizumab ophthalmic
rabibizumab, ranibizumab ophthalmic
ramibizumab, ranibizumab ophthalmic
rajibizumab, ranibizumab ophthalmic
rahibizumab, ranibizumab ophthalmic
ranubizumab, ranibizumab ophthalmic
ranjbizumab, ranibizumab ophthalmic
rankbizumab, ranibizumab ophthalmic
ranobizumab, ranibizumab ophthalmic
ran9bizumab, ranibizumab ophthalmic
ran8bizumab, ranibizumab ophthalmic
ranivizumab, ranibizumab ophthalmic
raninizumab, ranibizumab ophthalmic
ranihizumab, ranibizumab ophthalmic
ranigizumab, ranibizumab ophthalmic
ranibuzumab, ranibizumab ophthalmic
ranibjzumab, ranibizumab ophthalmic
ranibkzumab, ranibizumab ophthalmic
ranibozumab, ranibizumab ophthalmic
ranib9zumab, ranibizumab ophthalmic
ranib8zumab, ranibizumab ophthalmic
ranibixumab, ranibizumab ophthalmic
ranibisumab, ranibizumab ophthalmic
ranibiaumab, ranibizumab ophthalmic
ranibizymab, ranibizumab ophthalmic
ranibizhmab, ranibizumab ophthalmic
ranibizjmab, ranibizumab ophthalmic
ranibizimab, ranibizumab ophthalmic
ranibiz8mab, ranibizumab ophthalmic
ranibiz7mab, ranibizumab ophthalmic
ranibizunab, ranibizumab ophthalmic
ranibizukab, ranibizumab ophthalmic
ranibizujab, ranibizumab ophthalmic
ranibizumzb, ranibizumab ophthalmic
ranibizumsb, ranibizumab ophthalmic
ranibizumwb, ranibizumab ophthalmic
ranibizumqb, ranibizumab ophthalmic
ranibizumav, ranibizumab ophthalmic
ranibizuman, ranibizumab ophthalmic
ranibizumah, ranibizumab ophthalmic
ranibizumag, anibizumab ophthalmic
ranibizumab, rnibizumab ophthalmic
ranibizumab, raibizumab ophthalmic
ranibizumab, ranbizumab ophthalmic
ranibizumab, raniizumab ophthalmic
ranibizumab, ranibzumab ophthalmic
ranibizumab, ranibiumab ophthalmic
ranibizumab, ranibizmab ophthalmic
ranibizumab, ranibizuab ophthalmic
ranibizumab, ranibizumb ophthalmic
ranibizumab, ranibizuma ophthalmic
ranibizumab, ranibizumabophthalmic
ranibizumab, ranibizumab phthalmic
ranibizumab, ranibizumab ohthalmic
ranibizumab, ranibizumab opthalmic
ranibizumab, ranibizumab ophhalmic
ranibizumab, ranibizumab ophtalmic
ranibizumab, ranibizumab ophthlmic
ranibizumab, ranibizumab ophthamic
ranibizumab, ranibizumab ophthalic
ranibizumab, ranibizumab ophthalmc
ranibizumab, ranibizumab ophthalmi
ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic
ranibizumab, ranibizumab ophthalmic
anibizumab, ranibizumab ophthalmic
rnibizumab, ranibizumab ophthalmic
raibizumab, ranibizumab ophthalmic
ranbizumab, ranibizumab ophthalmic
raniizumab, ranibizumab ophthalmic
ranibzumab, ranibizumab ophthalmic
ranibiumab, ranibizumab ophthalmic
ranibizmab, ranibizumab ophthalmic
ranibizuab, ranibizumab ophthalmic
ranibizumb, ranibizumab ophthalmic
ranibizuma, arnibizumab ophthalmic
ranibizumab, rnaibizumab ophthalmic
ranibizumab, rainbizumab ophthalmic
ranibizumab, ranbiizumab ophthalmic
ranibizumab, raniibzumab ophthalmic
ranibizumab, ranibziumab ophthalmic
ranibizumab, ranibiuzmab ophthalmic
ranibizumab, ranibizmuab ophthalmic
ranibizumab, ranibizuamb ophthalmic
ranibizumab, ranibizumba ophthalmic
ranibizumab, ranibizuma bophthalmic
ranibizumab, ranibizumabo phthalmic
ranibizumab, ranibizumab pohthalmic
ranibizumab, ranibizumab ohpthalmic
ranibizumab, ranibizumab opthhalmic
ranibizumab, ranibizumab ophhtalmic
ranibizumab, ranibizumab ophtahlmic
ranibizumab, ranibizumab ophthlamic
ranibizumab, ranibizumab ophthamlic
ranibizumab, ranibizumab ophthalimc
ranibizumab, ranibizumab ophthalmci
ranibizumab, ranibizumab ophthalmi
c ranibizumab, ranibizumab ophthalmic
ranibizumab, ranibizumab ophthalmic
r anibizumab, ranibizumab ophthalmic
arnibizumab, ranibizumab ophthalmic
rnaibizumab, ranibizumab ophthalmic
rainbizumab, ranibizumab ophthalmic
ranbiizumab, ranibizumab ophthalmic
raniibzumab, ranibizumab ophthalmic
ranibziumab, ranibizumab ophthalmic
ranibiuzmab, ranibizumab ophthalmic
ranibizmuab, ranibizumab ophthalmic
ranibizuamb, ranibizumab ophthalmic
ranibizumba, rranibizumab ophthalmic
ranibizumab, raanibizumab ophthalmic
ranibizumab, rannibizumab ophthalmic
ranibizumab, raniibizumab ophthalmic
ranibizumab, ranibbizumab ophthalmic
ranibizumab, ranibiizumab ophthalmic
ranibizumab, ranibizzumab ophthalmic
ranibizumab, ranibizuumab ophthalmic
ranibizumab, ranibizummab ophthalmic
ranibizumab, ranibizumaab ophthalmic
ranibizumab, ranibizumabb ophthalmic
ranibizumab, ranibizumab ophthalmic
ranibizumab, ranibizumab oophthalmic
ranibizumab, ranibizumab opphthalmic
ranibizumab, ranibizumab ophhthalmic
ranibizumab, ranibizumab ophtthalmic
ranibizumab, ranibizumab ophthhalmic
ranibizumab, ranibizumab ophthaalmic
ranibizumab, ranibizumab ophthallmic
ranibizumab, ranibizumab ophthalmmic
ranibizumab, ranibizumab ophthalmiic
ranibizumab, ranibizumab ophthalmicc
ranibizumab, ranibizumab ophthalmic
ranibizumab, ranibizumab ophthalmic
ranibizumab, ranibizumab ophthalmic
rranibizumab, ranibizumab ophthalmic
raanibizumab, ranibizumab ophthalmic
rannibizumab, ranibizumab ophthalmic
raniibizumab, ranibizumab ophthalmic
ranibbizumab, ranibizumab ophthalmic
ranibiizumab, ranibizumab ophthalmic
ranibizzumab, ranibizumab ophthalmic
ranibizuumab, ranibizumab ophthalmic
ranibizummab, ranibizumab ophthalmic
ranibizumaab, ranibizumab ophthalmic
ranibizumabb, etc.
Tags: ranibizumab ophthalmic
Ranibizumab
|